The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors
Open accessAbstract
NAC (N-acetyl-L-cysteine) is commonly used to identify and test ROS (reactive oxygen species) inducers, and to inhibit ROS. In the present study, we identified inhibition of proteasome inhibitors as a novel activity of NAC. Both NAC and catalase, another known scavenger of ROS, similarly inhibited ROS levels and apoptosis associated with H2O2. However, only NAC, and not catalase or another ROS scavenger Trolox, was able to prevent effects linked to proteasome inhibition, such as protein stabilization, apoptosis and accumulation of ubiquitin conjugates. These observations suggest that NAC has a dual activity as an inhibitor of ROS and proteasome inhibitors. Recently, NAC was used as a ROS inhibitor to functionally characterize a novel anticancer compound, piperlongumine, leading to its description as a ROS inducer. In contrast, our own experiments showed that this compound depicts features of proteasome inhibitors including suppression of FOXM1 (Forkhead box protein M1), stabilization of cellular proteins, induction of ROS-independent apoptosis and enhanced accumulation of ubiquitin conjugates. In addition, NAC, but not catalase or Trolox, interfered with the activity of piperlongumine, further supporting that piperlongumine is a proteasome inhibitor. Most importantly, we showed that NAC, but not other ROS scavengers, directly binds to proteasome inhibitors. To our knowledge, NAC is the first known compound that directly interacts with and antagonizes the activity of proteasome inhibitors. Taken together, the findings of the present study suggest that, as a result of the dual nature of NAC, data interpretation might not be straightforward when NAC is utilized as an antioxidant to demonstrate ROS involvement in drug-induced apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Selective killing of cancer cells by a small molecule targeting the stress response to ROS
Raj, L., Ide, T., Gurkar, A. U., Foley, M., Schenone, M., Li, X., Tolliday, N. J., Golub, T. R., Carr, S. A., Shamji, A. F., et al. (2011) · Nature · doi:10.1038/nature10167 · Cited by 1,030
RetractedOxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?
Malhotra, J. D., & Kaufman, R. J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1782 · Cited by 1,563
The proteasome: a suitable antineoplastic target
Adams, J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1361 · Cited by 1,201
Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.009 · Cited by 1,080
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
Nogueira, V., Park, Y., Chen, C.-C., Xu, P.-Z., Chen, M.-L., Tonic, I., Unterman, T., & Hay, N. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.003 · Cited by 780
Self-citationAzad, M. B., Chen, Y., & Gibson, S. B. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2270 · Cited by 760
Regulation and measurement of oxidative stress in apoptosis
Curtin, J. F., Donovan, M., & Cotter, T. G. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00070-4 · Cited by 584
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
Kisselev, A. F., van der Linden, W. A., & Overkleeft, H. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.003 · Cited by 527
Groll, M., Berkers, C. R., Ploegh, H. L., & Ovaa, H. (2006) · Structure · doi:10.1016/j.str.2005.11.019 · Cited by 473
Fribley, A., Zeng, Q., & Wang, C.-Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9695-9704.2004 · Cited by 424
Lactacystin, Proteasome Function, and Cell Fate
Fenteany, G., & Schreiber, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8545 · Cited by 410
Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin
Dick, L. R., Cruikshank, A. A., Grenier, L., Melandri, F. D., Nunes, S. L., & Stein, R. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7273 · Cited by 368
Proteasome inhibitors in cancer therapy
Crawford, L. J., Walker, B., & Irvine, A. E. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0121-7 · Cited by 299
N-acetylcysteine, reactive oxygen species and beyond
Sun, S.-Y. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.2.10583 · Cited by 288
The transcription factor FOXM1 is a cellular target of the natural product thiostrepton
Hegde, N. S., Sanders, D. A., Rodriguez, R., & Balasubramanian, S. (2011) · Nature Chemistry · doi:10.1038/nchem.1114 · Cited by 269
Major, M. L., Lepe, R., & Costa, R. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2649-2661.2004 · Cited by 266
FoxM1, a critical regulator of oxidative stress during oncogenesis
Park, H. J., Carr, J. R., Wang, Z., Nogueira, V., Hay, N., Tyner, A. L., Lau, L. F., Costa, R. H., & Raychaudhuri, P. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.239 · Cited by 235
Self-citationIdentification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1
Radhakrishnan, S. K., Bhat, U. G., Hughes, D. E., Wang, I.-C., Costa, R. H., & Gartel, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1576 · Cited by 234
Self-citationMechanistic Studies on the Inactivation of the Proteasome by Lactacystin in Cultured Cells
Dick, L. R., Cruikshank, A. A., Destree, A. T., Grenier, L., McCormack, T. A., Melandri, F. D., Nunes, S. L., Palombella, V. J., Parent, L. A., Plamondon, L., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.182 · Cited by 228
Proteasome inhibitors: antitumor effects and beyond
Nencioni, A., Grünebach, F., Patrone, F., Ballestrero, A., & Brossart, P. (2007) · Leukemia · doi:10.1038/sj.leu.2404444 · Cited by 220
Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
Bhat, U. G., Halasi, M., & Gartel, A. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005592 · Cited by 194
Self-citationFoxM1 Is a General Target for Proteasome Inhibitors
Bhat, U. G., Halasi, M., & Gartel, A. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006593 · Cited by 185
Self-citationHuang, C., Li, J., Ding, M., Leonard, S. S., Wang, L., Castranova, V., Vallyathan, V., & Shi, X. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103684200 · Cited by 93
A new target for proteasome inhibitors: FoxM1
Gartel, A. L. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903563364 · Cited by 92
Self-citationPiperlongumine induces inhibition of the ubiquitin–proteasome system in cancer cells
Jarvius, M., Fryknäs, M., D’Arcy, P., Sun, C., Rickardson, L., Gullbo, J., Haglund, C., Nygren, P., Linder, S. T., & Larsson, R. L. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.017 · Cited by 57
Proteasome inhibitor MG-132 induces C6 glioma cell apoptosis via oxidative stress
Fan, W., Hou, Y., Meng, F.-K., Wang, X., Luo, Y., & Ge, P. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.16 · Cited by 45
Zhang, S., Shi, Y., Jin, H., Liu, Z., Zhang, L., & Zhang, L. (2009) · Journal of Molecular Modeling · doi:10.1007/s00894-009-0515-0 · Cited by 34
Cited by
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells
Wei, R., Zhao, Y., Wang, J., Yang, X., Li, S., Wang, Y., Yang, X., Fei, J., Hao, X., Zhao, Y., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59404 · Cited by 434
Jin, Y., Ji, W., Yang, H., Chen, S., Zhang, W., & Duan, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00454-7 · Cited by 399
A Mitochondria-Targeted Cryptocyanine-Based Photothermogenic Photosensitizer
Jung, H. S., Lee, J.-H., Kim, K., Koo, S., Verwilst, P., Sessler, J. L., Kang, C., & Kim, J. S. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b04263 · Cited by 371
Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl‐p53 pathway
Zhou, Y., Que, K., Zhang, Z., Yi, Z. J., Zhao, P. X., You, Y., Gong, J., & Liu, Z. (2018) · Cancer Medicine · doi:10.1002/cam4.1670 · Cited by 336
Metadata
- Authors
- Halasi, M., Wang, M., Chavan, T. S., Gaponenko, V., Hay, N., & Gartel, A. L.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2013-08-09
- Volume
- 454
- Issue
- 2
- Pages
- 201-208
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2335332173
- Cited by
- 366
- References
- 30
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.